This inventor holds 18 USPTO granted patents and 4 published patent applications and 6 EPO patents, primarily in Nucleic Acid Therapeutics. Top assignees: Merck Sharp + Dohme Corp., Gilead Pharmasset LLC, Sirna Therapeutics, Inc.. Active years: 2013-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Kenilworth, NJ (US) (2018 - 2020)
- Princeton, NJ (US) (2013 - 2023)
Company Filing History:
12 out of 2,405 
4 out of 81 
2 out of 140 Years Active: 2013-2023
Areas of Expertise:
Title: The Innovative Contributions of Wonsuk Chang
Introduction
Wonsuk Chang, an accomplished inventor based in Princeton, NJ, has made significant strides in the field of biochemistry and pharmacology. With a remarkable portfolio of 16 patents, Chang's work primarily focuses on developing novel compounds that activate critical immune pathways. Through his inventive contributions, he continues to influence advancements in therapeutic modalities.
Latest Patents
Wonsuk Chang's recent patents showcase his innovative approach to enhancing immune responses. One notable patent is for "Cyclic di-nucleotide compounds as STING agonists." This invention presents a class of polycyclic compounds designed to induce type I interferon production, highlighting their potential as STING active agents. Additionally, he has developed "Substituted RIG-I agonists: compositions and methods thereof," which details compositions that activate the RIG-I pathway, utilizing single-strand oligonucleotides that can form self-complementary structures.
Career Highlights
Throughout his career, Wonsuk Chang has been associated with prominent organizations such as Merck Sharp & Dohme Corporation and Gilead Pharmasset LLC. His experiences at these companies have enriched his expertise and allowed him to make substantial contributions to the fields of immunology and drug development.
Collaborations
Chang has worked closely with noteworthy colleagues like Jared N. Cumming and Benjamin Wesley Trotter, fostering collaborations that have furthered research and innovation. These partnerships have not only enhanced his own work but have also led to important advancements in their respective fields.
Conclusion
Wonsuk Chang's inventive spirit and dedication to research have established him as a pioneering figure in the development of immune-modulatory compounds. His ongoing contributions underscore the importance of innovation in the medical and pharmaceutical landscape, paving the way for potential breakthroughs in treating various diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile